156.30
前日終値:
$155.54
開ける:
$158
24時間の取引高:
1.74M
Relative Volume:
0.60
時価総額:
$43.07B
収益:
$21.37B
当期純損益:
$1.41B
株価収益率:
39.63
EPS:
3.9437
ネットキャッシュフロー:
$3.07B
1週間 パフォーマンス:
+3.28%
1か月 パフォーマンス:
+3.40%
6か月 パフォーマンス:
-22.89%
1年 パフォーマンス:
-9.63%
Becton Dickinson Co Stock (BDX) Company Profile
Compare BDX vs ISRG, MDLN, ALC, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
BDX
Becton Dickinson Co
|
156.30 | 42.86B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
ISRG
Intuitive Surgical Inc
|
427.30 | 153.29B | 10.58B | 3.00B | 2.83B | 8.2437 |
|
MDLN
Medline Inc
|
43.01 | 36.15B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
ALC
Alcon Inc
|
66.87 | 33.32B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
RMD
Resmed Inc
|
219.75 | 31.68B | 5.54B | 1.52B | 1.74B | 10.37 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-10 | 再開されました | Goldman | Neutral |
| 2026-02-10 | 再開されました | Barclays | Overweight |
| 2026-02-03 | 再開されました | Citigroup | Buy |
| 2025-09-25 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2025-05-22 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-05-02 | ダウングレード | Goldman | Buy → Neutral |
| 2025-05-02 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2025-05-02 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2025-05-01 | ダウングレード | BofA Securities | Buy → Neutral |
| 2025-05-01 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2025-05-01 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2024-10-01 | アップグレード | Citigroup | Neutral → Buy |
| 2024-05-30 | 開始されました | Goldman | Buy |
| 2023-07-24 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2023-05-30 | 再開されました | Morgan Stanley | Overweight |
| 2023-05-05 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2023-04-12 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-01-03 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-12-12 | アップグレード | Citigroup | Sell → Neutral |
| 2022-07-11 | ダウングレード | Citigroup | Neutral → Sell |
| 2022-06-24 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2022-03-18 | 再開されました | Raymond James | Mkt Perform |
| 2022-03-02 | 再開されました | BofA Securities | Neutral |
| 2021-12-08 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2021-08-06 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2021-05-25 | 開始されました | Barclays | Equal Weight |
| 2020-12-15 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-12-15 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-07-09 | アップグレード | Barclays | Equal Weight → Overweight |
| 2020-06-01 | 再開されました | Goldman | Buy |
| 2020-03-05 | 開始されました | Citigroup | Neutral |
| 2020-02-07 | ダウングレード | Cowen | Outperform → Market Perform |
| 2020-02-07 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-07 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2020-02-06 | ダウングレード | Cowen | Outperform → Market Perform |
| 2020-01-08 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2019-05-13 | アップグレード | Barclays | Equal Weight → Overweight |
| 2018-12-07 | 開始されました | Deutsche Bank | Buy |
| 2018-10-16 | 開始されました | Barclays | Equal Weight |
| 2018-06-21 | アップグレード | JP Morgan | Neutral → Overweight |
| 2018-04-10 | アップグレード | Citigroup | Neutral → Buy |
| 2018-01-19 | 再開されました | BofA/Merrill | Buy |
| 2018-01-05 | アップグレード | Citigroup | Sell → Neutral |
| 2018-01-05 | 開始されました | KeyBanc Capital Mkts | Overweight |
| 2018-01-03 | 開始されました | Evercore ISI | Outperform |
| 2017-12-29 | 繰り返されました | Deutsche Bank | Buy |
すべてを表示
Becton Dickinson Co (BDX) 最新ニュース
Eli Lilly and Novo Nordisk Are Fine -- but These 2 Stocks Could Be an Even Better Way to Invest in the GLP-1 Boom - The Motley Fool
Becton Dickinson and Co steadies operations as healthcare demand evolves - AD HOC NEWS
Becton Dickinson & Co. stock outperforms competitors despite losses on the day - MarketWatch
Form 4 Becton Dickinson and Co For: 6 July By Investing.com - Investing.com Canada
Becton, Dickinson and Company (BDX) Stock Analysis: Evaluating Growth Potential and Analyst Ratings - DirectorsTalk Interviews
Becton Dickinson stock gains after company lifts earnings outlook By Investing.com - Investing.com Nigeria
Becton Dickinson stock holds its setup. Focus shifts to business fundamentals. - AD HOC NEWS
Is It Too Late to Buy Becton Dickinson & Co (BDX) After 3.4% Ral - GuruFocus
Becton Dickinson & Co. stock outperforms competitors on strong trading day - MarketWatch
Becton Dickinson holds steady as investors await a fresh catalyst - AD HOC NEWS
Becton, Dickinson and Company: Now Is A Great Time To Buy (NYSE:BDX) - Seeking Alpha
Becton Dickinson & Co. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
BD (BDX) Receives Vizient Innovative Technology Contract for CentroVena One Insertion System - Insider Monkey
List of 36 Acquisitions by Becton Dickinson (Jul 2026) - Tracxn
Becton Dickinson (NYSE:BDX) Advances in NYSE Composite After Vizient Deal - Kalkine Media
Becton Dickinson (BDX) Wins Vizient Contract As Fair Value Stays In Focus - simplywall.st
Becton Dickinson & Co. stock underperforms Tuesday when compared to competitors - MarketWatch
Becton Dickinson updates fiscal 2026 outlook, shares steady after cautious guidance - AD HOC NEWS
Form 4 Becton Dickinson and Co For: 26 June By Investing.com - Investing.com India
Insider Sell: Michael Feld Sells Shares of Becton Dickinson & Co (BDX) - GuruFocus
Michael Feld sells $11,460 of Becton Dickinson stock By Investing.com - Investing.com Nigeria
Michael Feld sells $11,460 of Becton Dickinson stock - Investing.com
Becton Dickinson & Co (BDX) Stock Up 3.0% and Still Undervalued -- GF Score: 76/100 - GuruFocus
Becton Dickinson EVP sells $160,226 in BDX shares By Investing.com - Investing.com South Africa
Becton Dickinson EVP sells $160,226 in BDX shares - Investing.com UK
AQR Trend Total Return Fund's Becton Dickinson & Co(BDX) Holding History - GuruFocus
Form 4 Becton Dickinson and Co For: 25 June By Investing.com - Investing.com Australia
Insider Sell: Michael Garrison Sells 1,100 Shares of Becton Dick - GuruFocus
Becton Dickinson and Co (BDX) Valuation: PE, PB & Fair Value Analysis - TradingKey
BD’s central line system gets Vizient’s innovation seal - Stock Titan
Becton Dickinson (BDX) Issues Voluntary Recall for Select Skin Preparation Products - Insider Monkey
Becton Dickinson & Co. stock underperforms Monday when compared to competitors - MarketWatch
Should BD’s Class I Spinal Tray Recalls Over Supplier Issues Require Action From Becton Dickinson (BDX) Investors? - simplywall.st
Becton Dickinson and Co (BDX) Institutional Confidence - TradingKey
Becton Dickinson and Co (BDX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Becton Dickinson and Co (BDX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Becton Dickinson and Co (BDX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Becton Dickinson and Co (BDX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Becton Dickinson and Co (BDX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Becton Dickinson and Co (BDX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Becton Dickinson & Co. stock underperforms Wednesday when compared to competitors - MarketWatch
Deals tracker: Baptist Health acquires Arkansas hospital - Modern Healthcare
BofA Trims Becton Dickinson (BDX) Target as Medtech Headwinds Persist - Insider Monkey
BofA Adjusts Price Target on Becton, Dickinson and Company to $170 From $177 - Moomoo
Becton Dickinson and Co Stock (US0758871091): Valuation Check As Shares Lag 2026 Highs - AD HOC NEWS
Is Becton, Dickinson and Company (BDX) A Good Stock To Buy Now? - Yahoo Finance
Becton Dickinson Co (BDX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):